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Abstract 
Extramedullary hematopoiesis (EMH) is a rare cause of spinal cord compression (SCC). EMH 
represents the growth of blood cells outside of the bone marrow and occurs in a variety of 
hematologic illnesses, including various types of anemia and myeloproliferative disorders. 
Although EMH usually occurs in the liver, spleen, and lymph nodes, it may also occur with- 
in the spinal canal. When this occurs, the mass effect can compress the spinal cord, potential-
ly leading to the development of neurological deficits. We present a case of SCC secondary 
to EMH. This report illustrates the importance of considering EMH in the differential diagno-
sis of SCC, even in the absence of signs of its most common etiologies. 
 © 2016 The Author(s) 
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Extramedullary hematopoiesis (EMH) is defined as the noncancerous proliferation of 
hematopoietic tissue outside the bone marrow. The hematologic etiologies vary in patho-
physiology, but most of them result in a state of anemia in which there are not enough func-
tional red blood cells to satiate the body’s oxygen demands. Conditions that can reduce the 
amount of functional red blood cells include thalassemia, sickle cell anemia, acquired hemo-
lytic anemia, and vitamin B12 or folate deficiency. Anemia can also be caused by bone mar-
row radiation used as treatment for some other condition [1–3]. It can also be caused by 
myelophthisic diseases in which the bone marrow is disrupted, such as leukemia, lymphoma, 
or myelofibrosis [4]. Congenital hematologic etiologies are some of the more common causes 
of EMH, and among these thalassemia is particularly suspect [5, 6]. EMH exists as a mecha-
nism to compensate for abnormally low levels of functional red blood cells, but can become 
pathological if it disrupts the other functions of the body [1, 2]. 
The most frequent sites of EMH are the liver, spleen, and lymph nodes. Less common 
sites include the retroperitoneal tissue, kidneys, adrenal glands, paravertebral area, thymus, 
breasts, sweat glands, pleura, prostate, and broad ligaments [1, 6]. Even less common ectopic 
locations include peripheral nerves and the cranial dura mater [1]. 
Very rarely does EMH occur in the spinal canal [2]. The first case of spinal cord com-
pression (SCC) secondary to EMH was reported by Gatto et al. [7] in 1954. Among the docu-
mented episodes of thalassemia-associated EMH, intraspinally located growths occur in 11–
15% of cases [8, 9]. Within the spine, the most common site is the thoracic region, followed 
by the lumbar region [1]. Importantly, the thoracic spine can be problematic for EMH be-
cause the spinal canal is especially narrow in this region [1, 3, 10]. There are several theories 
that attempt to explain the pathophysiology of EMH within the intraspinal space, including 
the possibility of direct extension of hematopoietic material from the medulla of the verte-
bral body [2]. Other models are embolism of hematopoietic tissue into the intraspinal space 
as well as anomalous activation of embryonic stem cells that reside in this area [11]. 
If there is a growth in an abnormal location within the body, it follows that naturally re-
siding material might be pathologically displaced via a mass effect. While this does not al-
ways result in a loss of function, EMH within the spinal cord can be associated with signifi-
cant morbidity. One serious complication is SCC [5]. The clinical presentation of SCC second-
ary to EMH may include back pain, sensory deficits, motor deficits, bowel and bladder dys-
function, and complete paralysis among its symptoms [1, 3]. Its severity can range from mild 
sensory and motor symptoms to total paralysis, and damage can be irreversible if not cor-
rected expeditiously [1]. We present the case of a patient who developed signs and symp-
toms of EMH-induced SCC, but who lacked any sign of its known etiologies. 
Case Report 
Our patient was a 51-year-old female who presented with a 1-week history of lower ex-
tremity weakness and mid-thoracic back pain. The patient had a known history of breast 
cancer diagnosed 10 years ago, and was coded status post mastectomy and radiation. On 
physical examination, she had 4/5 bilateral lower extremity weakness and diminished sen-
sation below the T4 spinal level. 
Magnetic resonance imaging (MRI) revealed a 1.6 × 1.0 × 9.7 cm large enhancing extra-
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was near-complete effacement of the spinal cord resulting in SCC. Large bulky enhancing 
bilateral paraspinal masses were also seen in addition to multiple masses in the lungs and 
liver that were compatible with metastatic lesions. 
Given the patient’s neurological deficits and MRI findings, a T4–T8 laminectomy was 
performed to decompress the spinal cord and resect the lesion. Intraoperatively, the bone 
was noted to be very soft and the marrow appeared grossly abnormal. The epidural lesion 
was encased within a capsule, allowing improved resection. The spinal cord itself was signif-
icantly compressed and deformed from the mass effect of the lesion. After resection of the 
lesion, the spinal cord was noted to pulsate, which indicated adequate decompression. An 
initial frozen section of the bone revealed marrow elements with trilineage hematopoiesis, 
and a frozen section of the lesion itself revealed a hypercellular lesion. 
Microscopic examination revealed the resected mass to be composed of densely cellular 
hematopoietic marrow showing trilineage hematopoiesis with marked erythroid hyperpla-
sia. Immunohistochemical stains confirmed the presence of all three hematopoietic lineages 
(fig. 2). There was no evidence of any metastatic tumor, lymphoma, or leukemia. 
The patient recovered well from surgery, and her lower extremities returned to full 
strength several days following surgery. Upon receiving the pathology, the patient was start-
ed on adjuvant radiation therapy. A second round of radiation therapy was performed to 
further shrink the paraspinal masses adjacent to the spinal column. A 3-month follow-up 
MRI of the spine demonstrated a decompressed spinal cord without recurrence at spinal 
levels T4–T8 (fig. 3). 
Discussion 
The first case of SCC secondary to EMH was reported in 1954, and was managed with 
surgical decompression and resection excision followed by local radiation [12]. The etiolo-
gies of EMH that have been associated with SCC are thalassemia, sickle cell anemia, myelofi-
brosis, polycythemia vera, acute myeloid leukemia, and myelodysplasia [2]. Among these 
sources, thalassemia is the most frequent culprit [5, 6]. However, thalassemia-associated 
EMH that results in SCC is far from common. In fact, in an article that collected and analyzed 
all such cases between 1954 and 1992, only 38 were found in the literature [6]. 
EMH-induced SCC is rare, but the morbidity associated with it is severe. Although most 
cases of intraspinal EMH are asymptomatic and are discovered incidentally with imaging, 
significant SCC can occur and result in permanent neurological injury. MRI is now consid-
ered to be the diagnostic modality of choice and considered superior to computed tomogra-
phy (CT). One advantage that MRI has over CT is that it does not involve radiation. Addition-
ally, it can effectively delineate the extent of the EMH mass as well as any involvement of 
meningeal and epidural tissue [1, 3, 13]. Biopsy is not always required for diagnosis [1], but 
if needed, it can be obtained via CT-guided needle biopsy [14]. CT imaging of active lesions 
will demonstrate soft tissue density on CT. Inactive lesions composed of iron deposits will 
demonstrate high density on CT, whereas fatty deposits will show low density [3, 15]. 
EMH-induced SCC must be diagnosed and treated quickly. Treatment options include 
surgery, radiotherapy, and hypertransfusion of red blood cells. Often, more than one type of 
therapy will be utilized for each patient [1, 5]. As an adjuvant, hydroxyurea is sometimes 
used for its myelosuppressive properties [1]. 
When EMH is associated with neurological deficits, surgical intervention is necessary to 
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tion of an EMH mass is not always possible due to the borderless nature of the hematopoiet-
ic process [6]. Surgery also has the associated risks of general anesthesia, which is generally 
required for spinal operations [13]. Although opinions vary, it is generally agreed that surgi-
cal management of EMH should be reserved for acute, severe, or recurrent cases [1, 5]. As 
our patient presented with the sudden onset of neurological symptoms that did not improve 
after 2 months, it was appropriate and necessary for the patient to be managed surgically. 
For many patients, radiotherapy is emerging as the treatment of choice for EMH-
induced SCC because it is of low risk and well tolerated. One group indicated that the EMH 
volume decreases by 16.4% immediately after radiotherapy [16]. However, one problem 
with radiotherapy is that it can exacerbate anemia by decreasing hematopoiesis in the sur-
rounding tissue [1], and therapy cannot be initiated without establishing a diagnosis first 
[13]. 
Hypertransfusion of red bloods cells is another rising therapy that is considered to be 
the least invasive option for the management of EMH-induced SCC [17]. In addition to its 
therapeutic benefits, hypertransfusion can also be diagnostic, since a response to this treat-
ment indicates an anemic etiology [1]. One problem with this type of treatment is that symp-
toms can recur shortly afterwards. Hypertransfusion appears to be the best option for mild 
cases or for diagnostic purposes [17]. 
Of the cases of EMH-induced SCC within the literature, both the treatments and out-
comes have varied widely. For example, one group successfully managed a patient who had 
chronic thalassemia intermedia with surgical decompression after hypertransfusion had 
failed to alleviate the neurological symptoms [13]. Another group had immediate success in 
treating thalassemia intermedia in their patient with hypertransfusion, and the neurological 
symptoms disappeared within a week [18]. Some other teams utilized hypertransfusion, and 
then added hydroxyurea for supportive myelosuppression [1, 19]. 
We present a case of EMH-induced SCC that occurred outside the context of a known 
hematologic or myeloproliferative disorder. This kind of presentation is rare, but it has pre-
viously been documented. One recent case describes a patient presenting with neck pain and 
stiffness after a minor trauma, which led to the discovery of a neck mass composed of benign 
hematopoietic tissue. The patient had no known hematologic or myeloproliferative disease 
[20]. Our patient was similar in that there was no underlying hematologic disease, and the 
diagnosis was initially suspected to be a new breast cancer metastasis. Given that the treat-
ment for EMH varies dramatically from that for cancer and other more common etiologies of 
SCC, this case report demonstrates the importance of being mindful of rare diseases. 
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Fig. 1. Sagittal (upper panels) and axial (lower panels) T1-weighted, T1-weighted with Gd (T1 + C), and T2-
weighted fat suppression (T2-Stir) sequences showing a large enhancing extradural mass in the dorsal 
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Fig. 2. a, b Photomicrographs of tumor sections with H&E staining showing densely cellular hematopoietic 
marrow composed of hyperplastic erythroid elements admixed with myeloid cells and scattered megakar-
yocytes (large cells). c–e Immunohistochemical stains for myeloperoxidase (MPO), hemoglobin A (HgA), 
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Fig. 3. Sagittal (a) and axial (b) T2-weighted MRI sequences demonstrating the decompressed thoracic 
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